Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1652374

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1652374

Liposome and Microsphere Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multi User License)
USD 5925
PDF (Enterprise User License)
USD 7900

Add to Cart

This research report focuses on the Liposome and Microsphere Delivery System Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Market Overview

  • 1.1 Liposome and Microsphere Delivery System Product Introduction
  • 1.2 Global Liposome and Microsphere Delivery System Market Size Forecast
    • 1.2.1 Global Liposome and Microsphere Delivery System Sales Value (2020-2031)
    • 1.2.2 Global Liposome and Microsphere Delivery System Sales Volume (2020-2031)
    • 1.2.3 Global Liposome and Microsphere Delivery System Sales Price (2020-2031)
  • 1.3 Liposome and Microsphere Delivery System Market Trends & Drivers
    • 1.3.1 Liposome and Microsphere Delivery System Industry Trends
    • 1.3.2 Liposome and Microsphere Delivery System Market Drivers & Opportunity
    • 1.3.3 Liposome and Microsphere Delivery System Market Challenges
    • 1.3.4 Liposome and Microsphere Delivery System Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Liposome and Microsphere Delivery System Players Revenue Ranking (2024)
  • 2.2 Global Liposome and Microsphere Delivery System Revenue by Company (2020-2025)
  • 2.3 Global Liposome and Microsphere Delivery System Players Sales Volume Ranking (2024)
  • 2.4 Global Liposome and Microsphere Delivery System Sales Volume by Company Players (2020-2025)
  • 2.5 Global Liposome and Microsphere Delivery System Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Liposome and Microsphere Delivery System Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Liposome and Microsphere Delivery System Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Liposome and Microsphere Delivery System
  • 2.9 Liposome and Microsphere Delivery System Market Competitive Analysis
    • 2.9.1 Liposome and Microsphere Delivery System Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Liposome and Microsphere Delivery System Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome and Microsphere Delivery System as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Powder
    • 3.1.2 Preparation
  • 3.2 Global Liposome and Microsphere Delivery System Sales Value by Type
    • 3.2.1 Global Liposome and Microsphere Delivery System Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Liposome and Microsphere Delivery System Sales Value, by Type (2020-2031)
    • 3.2.3 Global Liposome and Microsphere Delivery System Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Liposome and Microsphere Delivery System Sales Volume by Type
    • 3.3.1 Global Liposome and Microsphere Delivery System Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Liposome and Microsphere Delivery System Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Liposome and Microsphere Delivery System Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Liposome and Microsphere Delivery System Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Drug Delivery
    • 4.1.2 Vaccine Development
    • 4.1.3 Diagnostic Imaging
  • 4.2 Global Liposome and Microsphere Delivery System Sales Value by Application
    • 4.2.1 Global Liposome and Microsphere Delivery System Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Liposome and Microsphere Delivery System Sales Value, by Application (2020-2031)
    • 4.2.3 Global Liposome and Microsphere Delivery System Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Liposome and Microsphere Delivery System Sales Volume by Application
    • 4.3.1 Global Liposome and Microsphere Delivery System Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Liposome and Microsphere Delivery System Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Liposome and Microsphere Delivery System Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Liposome and Microsphere Delivery System Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Liposome and Microsphere Delivery System Sales Value by Region
    • 5.1.1 Global Liposome and Microsphere Delivery System Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Liposome and Microsphere Delivery System Sales Value by Region (2020-2025)
    • 5.1.3 Global Liposome and Microsphere Delivery System Sales Value by Region (2026-2031)
    • 5.1.4 Global Liposome and Microsphere Delivery System Sales Value by Region (%), (2020-2031)
  • 5.2 Global Liposome and Microsphere Delivery System Sales Volume by Region
    • 5.2.1 Global Liposome and Microsphere Delivery System Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Liposome and Microsphere Delivery System Sales Volume by Region (2020-2025)
    • 5.2.3 Global Liposome and Microsphere Delivery System Sales Volume by Region (2026-2031)
    • 5.2.4 Global Liposome and Microsphere Delivery System Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Liposome and Microsphere Delivery System Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 5.4.2 North America Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 5.5.2 Europe Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Liposome and Microsphere Delivery System Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 5.7.2 South America Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Liposome and Microsphere Delivery System Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Liposome and Microsphere Delivery System Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Liposome and Microsphere Delivery System Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.3.2 United States Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.4.2 Europe Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.5.2 China Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.6.2 Japan Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.7.2 South Korea Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.9.2 India Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Gilead Sciences Ltd
    • 7.1.1 Gilead Sciences Ltd Company Information
    • 7.1.2 Gilead Sciences Ltd Introduction and Business Overview
    • 7.1.3 Gilead Sciences Ltd Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Gilead Sciences Ltd Liposome and Microsphere Delivery System Product Offerings
    • 7.1.5 Gilead Sciences Ltd Recent Development
  • 7.2 Pacira
    • 7.2.1 Pacira Company Information
    • 7.2.2 Pacira Introduction and Business Overview
    • 7.2.3 Pacira Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Pacira Liposome and Microsphere Delivery System Product Offerings
    • 7.2.5 Pacira Recent Development
  • 7.3 Shandong Luye Pharmaceutical Co., Ltd.
    • 7.3.1 Shandong Luye Pharmaceutical Co., Ltd. Company Information
    • 7.3.2 Shandong Luye Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.3.3 Shandong Luye Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Shandong Luye Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.3.5 Shandong Luye Pharmaceutical Co., Ltd. Recent Development
  • 7.4 Sun Pharmaceutical
    • 7.4.1 Sun Pharmaceutical Company Information
    • 7.4.2 Sun Pharmaceutical Introduction and Business Overview
    • 7.4.3 Sun Pharmaceutical Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Sun Pharmaceutical Liposome and Microsphere Delivery System Product Offerings
    • 7.4.5 Sun Pharmaceutical Recent Development
  • 7.5 Johnson & Johnson
    • 7.5.1 Johnson & Johnson Company Information
    • 7.5.2 Johnson & Johnson Introduction and Business Overview
    • 7.5.3 Johnson & Johnson Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Johnson & Johnson Liposome and Microsphere Delivery System Product Offerings
    • 7.5.5 Johnson & Johnson Recent Development
  • 7.6 Leadiant Biosciences (Sigma-Tau)
    • 7.6.1 Leadiant Biosciences (Sigma-Tau) Company Information
    • 7.6.2 Leadiant Biosciences (Sigma-Tau) Introduction and Business Overview
    • 7.6.3 Leadiant Biosciences (Sigma-Tau) Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Leadiant Biosciences (Sigma-Tau) Liposome and Microsphere Delivery System Product Offerings
    • 7.6.5 Leadiant Biosciences (Sigma-Tau) Recent Development
  • 7.7 Ipsen (Onivyde)
    • 7.7.1 Ipsen (Onivyde) Company Information
    • 7.7.2 Ipsen (Onivyde) Introduction and Business Overview
    • 7.7.3 Ipsen (Onivyde) Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Ipsen (Onivyde) Liposome and Microsphere Delivery System Product Offerings
    • 7.7.5 Ipsen (Onivyde) Recent Development
  • 7.8 Teva Pharmaceutical
    • 7.8.1 Teva Pharmaceutical Company Information
    • 7.8.2 Teva Pharmaceutical Introduction and Business Overview
    • 7.8.3 Teva Pharmaceutical Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Teva Pharmaceutical Liposome and Microsphere Delivery System Product Offerings
    • 7.8.5 Teva Pharmaceutical Recent Development
  • 7.9 Novartis
    • 7.9.1 Novartis Company Information
    • 7.9.2 Novartis Introduction and Business Overview
    • 7.9.3 Novartis Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Novartis Liposome and Microsphere Delivery System Product Offerings
    • 7.9.5 Novartis Recent Development
  • 7.10 Lipoid
    • 7.10.1 Lipoid Company Information
    • 7.10.2 Lipoid Introduction and Business Overview
    • 7.10.3 Lipoid Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Lipoid Liposome and Microsphere Delivery System Product Offerings
    • 7.10.5 Lipoid Recent Development
  • 7.11 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
    • 7.11.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Company Information
    • 7.11.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.11.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.11.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Recent Development
  • 7.12 Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
    • 7.12.1 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Company Information
    • 7.12.2 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.12.3 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.12.5 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Recent Development
  • 7.13 China Pharmaceutical Holding Group Co., Ltd.
    • 7.13.1 China Pharmaceutical Holding Group Co., Ltd. Company Information
    • 7.13.2 China Pharmaceutical Holding Group Co., Ltd. Introduction and Business Overview
    • 7.13.3 China Pharmaceutical Holding Group Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 China Pharmaceutical Holding Group Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.13.5 China Pharmaceutical Holding Group Co., Ltd. Recent Development
  • 7.14 Changzhou Jinyuan Pharmaceutical Co., Ltd.
    • 7.14.1 Changzhou Jinyuan Pharmaceutical Co., Ltd. Company Information
    • 7.14.2 Changzhou Jinyuan Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.14.3 Changzhou Jinyuan Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Changzhou Jinyuan Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.14.5 Changzhou Jinyuan Pharmaceutical Co., Ltd. Recent Development
  • 7.15 FormuMax Scientific, Inc.
    • 7.15.1 FormuMax Scientific, Inc. Company Information
    • 7.15.2 FormuMax Scientific, Inc. Introduction and Business Overview
    • 7.15.3 FormuMax Scientific, Inc. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 FormuMax Scientific, Inc. Liposome and Microsphere Delivery System Product Offerings
    • 7.15.5 FormuMax Scientific, Inc. Recent Development
  • 7.16 Oakwood Labs
    • 7.16.1 Oakwood Labs Company Information
    • 7.16.2 Oakwood Labs Introduction and Business Overview
    • 7.16.3 Oakwood Labs Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Oakwood Labs Liposome and Microsphere Delivery System Product Offerings
    • 7.16.5 Oakwood Labs Recent Development
  • 7.17 Fuisz Technologies Ltd
    • 7.17.1 Fuisz Technologies Ltd Company Information
    • 7.17.2 Fuisz Technologies Ltd Introduction and Business Overview
    • 7.17.3 Fuisz Technologies Ltd Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Fuisz Technologies Ltd Liposome and Microsphere Delivery System Product Offerings
    • 7.17.5 Fuisz Technologies Ltd Recent Development
  • 7.18 Delpharm
    • 7.18.1 Delpharm Company Information
    • 7.18.2 Delpharm Introduction and Business Overview
    • 7.18.3 Delpharm Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Delpharm Liposome and Microsphere Delivery System Product Offerings
    • 7.18.5 Delpharm Recent Development
  • 7.19 Terumois
    • 7.19.1 Terumois Company Information
    • 7.19.2 Terumois Introduction and Business Overview
    • 7.19.3 Terumois Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Terumois Liposome and Microsphere Delivery System Product Offerings
    • 7.19.5 Terumois Recent Development
  • 7.20 Powder Systems Limited
    • 7.20.1 Powder Systems Limited Company Information
    • 7.20.2 Powder Systems Limited Introduction and Business Overview
    • 7.20.3 Powder Systems Limited Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Powder Systems Limited Liposome and Microsphere Delivery System Product Offerings
    • 7.20.5 Powder Systems Limited Recent Development
  • 7.21 PolyMicrospheres
    • 7.21.1 PolyMicrospheres Company Information
    • 7.21.2 PolyMicrospheres Introduction and Business Overview
    • 7.21.3 PolyMicrospheres Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.21.4 PolyMicrospheres Liposome and Microsphere Delivery System Product Offerings
    • 7.21.5 PolyMicrospheres Recent Development
  • 7.22 AULBIO
    • 7.22.1 AULBIO Company Information
    • 7.22.2 AULBIO Introduction and Business Overview
    • 7.22.3 AULBIO Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.22.4 AULBIO Liposome and Microsphere Delivery System Product Offerings
    • 7.22.5 AULBIO Recent Development
  • 7.23 Shanghai Livzon Pharmaceutical Co., Ltd.
    • 7.23.1 Shanghai Livzon Pharmaceutical Co., Ltd. Company Information
    • 7.23.2 Shanghai Livzon Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.23.3 Shanghai Livzon Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.23.4 Shanghai Livzon Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.23.5 Shanghai Livzon Pharmaceutical Co., Ltd. Recent Development
  • 7.24 Beijing Biote Pharmaceutical Co., Ltd.
    • 7.24.1 Beijing Biote Pharmaceutical Co., Ltd. Company Information
    • 7.24.2 Beijing Biote Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.24.3 Beijing Biote Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.24.4 Beijing Biote Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.24.5 Beijing Biote Pharmaceutical Co., Ltd. Recent Development

8 Industry Chain Analysis

  • 8.1 Liposome and Microsphere Delivery System Industrial Chain
  • 8.2 Liposome and Microsphere Delivery System Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Liposome and Microsphere Delivery System Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Liposome and Microsphere Delivery System Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

TABLE OF CONTENTS

1 Market Overview

  • 1.1 Liposome and Microsphere Delivery System Product Introduction
  • 1.2 Global Liposome and Microsphere Delivery System Market Size Forecast
    • 1.2.1 Global Liposome and Microsphere Delivery System Sales Value (2020-2031)
    • 1.2.2 Global Liposome and Microsphere Delivery System Sales Volume (2020-2031)
    • 1.2.3 Global Liposome and Microsphere Delivery System Sales Price (2020-2031)
  • 1.3 Liposome and Microsphere Delivery System Market Trends & Drivers
    • 1.3.1 Liposome and Microsphere Delivery System Industry Trends
    • 1.3.2 Liposome and Microsphere Delivery System Market Drivers & Opportunity
    • 1.3.3 Liposome and Microsphere Delivery System Market Challenges
    • 1.3.4 Liposome and Microsphere Delivery System Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Liposome and Microsphere Delivery System Players Revenue Ranking (2024)
  • 2.2 Global Liposome and Microsphere Delivery System Revenue by Company (2020-2025)
  • 2.3 Global Liposome and Microsphere Delivery System Players Sales Volume Ranking (2024)
  • 2.4 Global Liposome and Microsphere Delivery System Sales Volume by Company Players (2020-2025)
  • 2.5 Global Liposome and Microsphere Delivery System Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Liposome and Microsphere Delivery System Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Liposome and Microsphere Delivery System Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Liposome and Microsphere Delivery System
  • 2.9 Liposome and Microsphere Delivery System Market Competitive Analysis
    • 2.9.1 Liposome and Microsphere Delivery System Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Liposome and Microsphere Delivery System Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome and Microsphere Delivery System as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Powder
    • 3.1.2 Preparation
  • 3.2 Global Liposome and Microsphere Delivery System Sales Value by Type
    • 3.2.1 Global Liposome and Microsphere Delivery System Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Liposome and Microsphere Delivery System Sales Value, by Type (2020-2031)
    • 3.2.3 Global Liposome and Microsphere Delivery System Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Liposome and Microsphere Delivery System Sales Volume by Type
    • 3.3.1 Global Liposome and Microsphere Delivery System Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Liposome and Microsphere Delivery System Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Liposome and Microsphere Delivery System Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Liposome and Microsphere Delivery System Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Drug Delivery
    • 4.1.2 Vaccine Development
    • 4.1.3 Diagnostic Imaging
  • 4.2 Global Liposome and Microsphere Delivery System Sales Value by Application
    • 4.2.1 Global Liposome and Microsphere Delivery System Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Liposome and Microsphere Delivery System Sales Value, by Application (2020-2031)
    • 4.2.3 Global Liposome and Microsphere Delivery System Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Liposome and Microsphere Delivery System Sales Volume by Application
    • 4.3.1 Global Liposome and Microsphere Delivery System Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Liposome and Microsphere Delivery System Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Liposome and Microsphere Delivery System Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Liposome and Microsphere Delivery System Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Liposome and Microsphere Delivery System Sales Value by Region
    • 5.1.1 Global Liposome and Microsphere Delivery System Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Liposome and Microsphere Delivery System Sales Value by Region (2020-2025)
    • 5.1.3 Global Liposome and Microsphere Delivery System Sales Value by Region (2026-2031)
    • 5.1.4 Global Liposome and Microsphere Delivery System Sales Value by Region (%), (2020-2031)
  • 5.2 Global Liposome and Microsphere Delivery System Sales Volume by Region
    • 5.2.1 Global Liposome and Microsphere Delivery System Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Liposome and Microsphere Delivery System Sales Volume by Region (2020-2025)
    • 5.2.3 Global Liposome and Microsphere Delivery System Sales Volume by Region (2026-2031)
    • 5.2.4 Global Liposome and Microsphere Delivery System Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Liposome and Microsphere Delivery System Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 5.4.2 North America Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 5.5.2 Europe Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Liposome and Microsphere Delivery System Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 5.7.2 South America Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Liposome and Microsphere Delivery System Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Liposome and Microsphere Delivery System Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Liposome and Microsphere Delivery System Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.3.2 United States Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.4.2 Europe Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.5.2 China Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.6.2 Japan Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.7.2 South Korea Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Liposome and Microsphere Delivery System Sales Value, 2020-2031
    • 6.9.2 India Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Liposome and Microsphere Delivery System Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Gilead Sciences Ltd
    • 7.1.1 Gilead Sciences Ltd Company Information
    • 7.1.2 Gilead Sciences Ltd Introduction and Business Overview
    • 7.1.3 Gilead Sciences Ltd Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Gilead Sciences Ltd Liposome and Microsphere Delivery System Product Offerings
    • 7.1.5 Gilead Sciences Ltd Recent Development
  • 7.2 Pacira
    • 7.2.1 Pacira Company Information
    • 7.2.2 Pacira Introduction and Business Overview
    • 7.2.3 Pacira Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Pacira Liposome and Microsphere Delivery System Product Offerings
    • 7.2.5 Pacira Recent Development
  • 7.3 Shandong Luye Pharmaceutical Co., Ltd.
    • 7.3.1 Shandong Luye Pharmaceutical Co., Ltd. Company Information
    • 7.3.2 Shandong Luye Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.3.3 Shandong Luye Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Shandong Luye Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.3.5 Shandong Luye Pharmaceutical Co., Ltd. Recent Development
  • 7.4 Sun Pharmaceutical
    • 7.4.1 Sun Pharmaceutical Company Information
    • 7.4.2 Sun Pharmaceutical Introduction and Business Overview
    • 7.4.3 Sun Pharmaceutical Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Sun Pharmaceutical Liposome and Microsphere Delivery System Product Offerings
    • 7.4.5 Sun Pharmaceutical Recent Development
  • 7.5 Johnson & Johnson
    • 7.5.1 Johnson & Johnson Company Information
    • 7.5.2 Johnson & Johnson Introduction and Business Overview
    • 7.5.3 Johnson & Johnson Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Johnson & Johnson Liposome and Microsphere Delivery System Product Offerings
    • 7.5.5 Johnson & Johnson Recent Development
  • 7.6 Leadiant Biosciences (Sigma-Tau)
    • 7.6.1 Leadiant Biosciences (Sigma-Tau) Company Information
    • 7.6.2 Leadiant Biosciences (Sigma-Tau) Introduction and Business Overview
    • 7.6.3 Leadiant Biosciences (Sigma-Tau) Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Leadiant Biosciences (Sigma-Tau) Liposome and Microsphere Delivery System Product Offerings
    • 7.6.5 Leadiant Biosciences (Sigma-Tau) Recent Development
  • 7.7 Ipsen (Onivyde)
    • 7.7.1 Ipsen (Onivyde) Company Information
    • 7.7.2 Ipsen (Onivyde) Introduction and Business Overview
    • 7.7.3 Ipsen (Onivyde) Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Ipsen (Onivyde) Liposome and Microsphere Delivery System Product Offerings
    • 7.7.5 Ipsen (Onivyde) Recent Development
  • 7.8 Teva Pharmaceutical
    • 7.8.1 Teva Pharmaceutical Company Information
    • 7.8.2 Teva Pharmaceutical Introduction and Business Overview
    • 7.8.3 Teva Pharmaceutical Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Teva Pharmaceutical Liposome and Microsphere Delivery System Product Offerings
    • 7.8.5 Teva Pharmaceutical Recent Development
  • 7.9 Novartis
    • 7.9.1 Novartis Company Information
    • 7.9.2 Novartis Introduction and Business Overview
    • 7.9.3 Novartis Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Novartis Liposome and Microsphere Delivery System Product Offerings
    • 7.9.5 Novartis Recent Development
  • 7.10 Lipoid
    • 7.10.1 Lipoid Company Information
    • 7.10.2 Lipoid Introduction and Business Overview
    • 7.10.3 Lipoid Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Lipoid Liposome and Microsphere Delivery System Product Offerings
    • 7.10.5 Lipoid Recent Development
  • 7.11 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
    • 7.11.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Company Information
    • 7.11.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.11.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.11.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Recent Development
  • 7.12 Shanghai SPH New ASIA Pharmaceutical Co., Ltd.
    • 7.12.1 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Company Information
    • 7.12.2 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.12.3 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.12.5 Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Recent Development
  • 7.13 China Pharmaceutical Holding Group Co., Ltd.
    • 7.13.1 China Pharmaceutical Holding Group Co., Ltd. Company Information
    • 7.13.2 China Pharmaceutical Holding Group Co., Ltd. Introduction and Business Overview
    • 7.13.3 China Pharmaceutical Holding Group Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 China Pharmaceutical Holding Group Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.13.5 China Pharmaceutical Holding Group Co., Ltd. Recent Development
  • 7.14 Changzhou Jinyuan Pharmaceutical Co., Ltd.
    • 7.14.1 Changzhou Jinyuan Pharmaceutical Co., Ltd. Company Information
    • 7.14.2 Changzhou Jinyuan Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.14.3 Changzhou Jinyuan Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Changzhou Jinyuan Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.14.5 Changzhou Jinyuan Pharmaceutical Co., Ltd. Recent Development
  • 7.15 FormuMax Scientific, Inc.
    • 7.15.1 FormuMax Scientific, Inc. Company Information
    • 7.15.2 FormuMax Scientific, Inc. Introduction and Business Overview
    • 7.15.3 FormuMax Scientific, Inc. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 FormuMax Scientific, Inc. Liposome and Microsphere Delivery System Product Offerings
    • 7.15.5 FormuMax Scientific, Inc. Recent Development
  • 7.16 Oakwood Labs
    • 7.16.1 Oakwood Labs Company Information
    • 7.16.2 Oakwood Labs Introduction and Business Overview
    • 7.16.3 Oakwood Labs Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Oakwood Labs Liposome and Microsphere Delivery System Product Offerings
    • 7.16.5 Oakwood Labs Recent Development
  • 7.17 Fuisz Technologies Ltd
    • 7.17.1 Fuisz Technologies Ltd Company Information
    • 7.17.2 Fuisz Technologies Ltd Introduction and Business Overview
    • 7.17.3 Fuisz Technologies Ltd Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Fuisz Technologies Ltd Liposome and Microsphere Delivery System Product Offerings
    • 7.17.5 Fuisz Technologies Ltd Recent Development
  • 7.18 Delpharm
    • 7.18.1 Delpharm Company Information
    • 7.18.2 Delpharm Introduction and Business Overview
    • 7.18.3 Delpharm Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Delpharm Liposome and Microsphere Delivery System Product Offerings
    • 7.18.5 Delpharm Recent Development
  • 7.19 Terumois
    • 7.19.1 Terumois Company Information
    • 7.19.2 Terumois Introduction and Business Overview
    • 7.19.3 Terumois Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Terumois Liposome and Microsphere Delivery System Product Offerings
    • 7.19.5 Terumois Recent Development
  • 7.20 Powder Systems Limited
    • 7.20.1 Powder Systems Limited Company Information
    • 7.20.2 Powder Systems Limited Introduction and Business Overview
    • 7.20.3 Powder Systems Limited Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Powder Systems Limited Liposome and Microsphere Delivery System Product Offerings
    • 7.20.5 Powder Systems Limited Recent Development
  • 7.21 PolyMicrospheres
    • 7.21.1 PolyMicrospheres Company Information
    • 7.21.2 PolyMicrospheres Introduction and Business Overview
    • 7.21.3 PolyMicrospheres Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.21.4 PolyMicrospheres Liposome and Microsphere Delivery System Product Offerings
    • 7.21.5 PolyMicrospheres Recent Development
  • 7.22 AULBIO
    • 7.22.1 AULBIO Company Information
    • 7.22.2 AULBIO Introduction and Business Overview
    • 7.22.3 AULBIO Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.22.4 AULBIO Liposome and Microsphere Delivery System Product Offerings
    • 7.22.5 AULBIO Recent Development
  • 7.23 Shanghai Livzon Pharmaceutical Co., Ltd.
    • 7.23.1 Shanghai Livzon Pharmaceutical Co., Ltd. Company Information
    • 7.23.2 Shanghai Livzon Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.23.3 Shanghai Livzon Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.23.4 Shanghai Livzon Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.23.5 Shanghai Livzon Pharmaceutical Co., Ltd. Recent Development
  • 7.24 Beijing Biote Pharmaceutical Co., Ltd.
    • 7.24.1 Beijing Biote Pharmaceutical Co., Ltd. Company Information
    • 7.24.2 Beijing Biote Pharmaceutical Co., Ltd. Introduction and Business Overview
    • 7.24.3 Beijing Biote Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.24.4 Beijing Biote Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings
    • 7.24.5 Beijing Biote Pharmaceutical Co., Ltd. Recent Development

8 Industry Chain Analysis

  • 8.1 Liposome and Microsphere Delivery System Industrial Chain
  • 8.2 Liposome and Microsphere Delivery System Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Liposome and Microsphere Delivery System Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Liposome and Microsphere Delivery System Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

Table 1. Liposome and Microsphere Delivery System Market Trends

Table 2. Liposome and Microsphere Delivery System Market Drivers & Opportunity

Table 3. Liposome and Microsphere Delivery System Market Challenges

Table 4. Liposome and Microsphere Delivery System Market Restraints

Table 5. Global Liposome and Microsphere Delivery System Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Liposome and Microsphere Delivery System Revenue Market Share by Company (2020-2025)

Table 7. Global Liposome and Microsphere Delivery System Sales Volume by Company (2020-2025) & (K L)

Table 8. Global Liposome and Microsphere Delivery System Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Liposome and Microsphere Delivery System Price by Company (2020-2025) & (US$/L)

Table 10. Key Manufacturers Liposome and Microsphere Delivery System Manufacturing Base and Headquarters

Table 11. Key Manufacturers Liposome and Microsphere Delivery System Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Liposome and Microsphere Delivery System

Table 13. Global Liposome and Microsphere Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome and Microsphere Delivery System as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Liposome and Microsphere Delivery System Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Liposome and Microsphere Delivery System Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Liposome and Microsphere Delivery System Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Liposome and Microsphere Delivery System Sales Market Share in Value by Type (2020-2025)

Table 20. Global Liposome and Microsphere Delivery System Sales Market Share in Value by Type (2026-2031)

Table 21. Global Liposome and Microsphere Delivery System Sales Volume by Type: 2020 VS 2024 VS 2031 (K L)

Table 22. Global Liposome and Microsphere Delivery System Sales Volume by Type (2020-2025) & (K L)

Table 23. Global Liposome and Microsphere Delivery System Sales Volume by Type (2026-2031) & (K L)

Table 24. Global Liposome and Microsphere Delivery System Sales Volume Market Share by Type (2020-2025)

Table 25. Global Liposome and Microsphere Delivery System Sales Volume Market Share by Type (2026-2031)

Table 26. Global Liposome and Microsphere Delivery System Price by Type (2020-2025) & (US$/L)

Table 27. Global Liposome and Microsphere Delivery System Price by Type (2026-2031) & (US$/L)

Table 28. Global Liposome and Microsphere Delivery System Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Liposome and Microsphere Delivery System Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Liposome and Microsphere Delivery System Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Liposome and Microsphere Delivery System Sales Market Share in Value by Application (2020-2025)

Table 32. Global Liposome and Microsphere Delivery System Sales Market Share in Value by Application (2026-2031)

Table 33. Global Liposome and Microsphere Delivery System Sales Volume by Application: 2020 VS 2024 VS 2031 (K L)

Table 34. Global Liposome and Microsphere Delivery System Sales Volume by Application (2020-2025) & (K L)

Table 35. Global Liposome and Microsphere Delivery System Sales Volume by Application (2026-2031) & (K L)

Table 36. Global Liposome and Microsphere Delivery System Sales Volume Market Share by Application (2020-2025)

Table 37. Global Liposome and Microsphere Delivery System Sales Volume Market Share by Application (2026-2031)

Table 38. Global Liposome and Microsphere Delivery System Price by Application (2020-2025) & (US$/L)

Table 39. Global Liposome and Microsphere Delivery System Price by Application (2026-2031) & (US$/L)

Table 40. Global Liposome and Microsphere Delivery System Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Liposome and Microsphere Delivery System Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Liposome and Microsphere Delivery System Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Liposome and Microsphere Delivery System Sales Value by Region (2020-2025) & (%)

Table 44. Global Liposome and Microsphere Delivery System Sales Value by Region (2026-2031) & (%)

Table 45. Global Liposome and Microsphere Delivery System Sales Volume by Region (K L): 2020 VS 2024 VS 2031

Table 46. Global Liposome and Microsphere Delivery System Sales Volume by Region (2020-2025) & (K L)

Table 47. Global Liposome and Microsphere Delivery System Sales Volume by Region (2026-2031) & (K L)

Table 48. Global Liposome and Microsphere Delivery System Sales Volume by Region (2020-2025) & (%)

Table 49. Global Liposome and Microsphere Delivery System Sales Volume by Region (2026-2031) & (%)

Table 50. Global Liposome and Microsphere Delivery System Average Price by Region (2020-2025) & (US$/L)

Table 51. Global Liposome and Microsphere Delivery System Average Price by Region (2026-2031) & (US$/L)

Table 52. Key Countries/Regions Liposome and Microsphere Delivery System Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Liposome and Microsphere Delivery System Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Liposome and Microsphere Delivery System Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Liposome and Microsphere Delivery System Sales Volume, (2020-2025) & (K L)

Table 56. Key Countries/Regions Liposome and Microsphere Delivery System Sales Volume, (2026-2031) & (K L)

Table 57. Gilead Sciences Ltd Company Information

Table 58. Gilead Sciences Ltd Introduction and Business Overview

Table 59. Gilead Sciences Ltd Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 60. Gilead Sciences Ltd Liposome and Microsphere Delivery System Product Offerings

Table 61. Gilead Sciences Ltd Recent Development

Table 62. Pacira Company Information

Table 63. Pacira Introduction and Business Overview

Table 64. Pacira Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 65. Pacira Liposome and Microsphere Delivery System Product Offerings

Table 66. Pacira Recent Development

Table 67. Shandong Luye Pharmaceutical Co., Ltd. Company Information

Table 68. Shandong Luye Pharmaceutical Co., Ltd. Introduction and Business Overview

Table 69. Shandong Luye Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 70. Shandong Luye Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings

Table 71. Shandong Luye Pharmaceutical Co., Ltd. Recent Development

Table 72. Sun Pharmaceutical Company Information

Table 73. Sun Pharmaceutical Introduction and Business Overview

Table 74. Sun Pharmaceutical Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 75. Sun Pharmaceutical Liposome and Microsphere Delivery System Product Offerings

Table 76. Sun Pharmaceutical Recent Development

Table 77. Johnson & Johnson Company Information

Table 78. Johnson & Johnson Introduction and Business Overview

Table 79. Johnson & Johnson Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 80. Johnson & Johnson Liposome and Microsphere Delivery System Product Offerings

Table 81. Johnson & Johnson Recent Development

Table 82. Leadiant Biosciences (Sigma-Tau) Company Information

Table 83. Leadiant Biosciences (Sigma-Tau) Introduction and Business Overview

Table 84. Leadiant Biosciences (Sigma-Tau) Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 85. Leadiant Biosciences (Sigma-Tau) Liposome and Microsphere Delivery System Product Offerings

Table 86. Leadiant Biosciences (Sigma-Tau) Recent Development

Table 87. Ipsen (Onivyde) Company Information

Table 88. Ipsen (Onivyde) Introduction and Business Overview

Table 89. Ipsen (Onivyde) Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 90. Ipsen (Onivyde) Liposome and Microsphere Delivery System Product Offerings

Table 91. Ipsen (Onivyde) Recent Development

Table 92. Teva Pharmaceutical Company Information

Table 93. Teva Pharmaceutical Introduction and Business Overview

Table 94. Teva Pharmaceutical Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 95. Teva Pharmaceutical Liposome and Microsphere Delivery System Product Offerings

Table 96. Teva Pharmaceutical Recent Development

Table 97. Novartis Company Information

Table 98. Novartis Introduction and Business Overview

Table 99. Novartis Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 100. Novartis Liposome and Microsphere Delivery System Product Offerings

Table 101. Novartis Recent Development

Table 102. Lipoid Company Information

Table 103. Lipoid Introduction and Business Overview

Table 104. Lipoid Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 105. Lipoid Liposome and Microsphere Delivery System Product Offerings

Table 106. Lipoid Recent Development

Table 107. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Company Information

Table 108. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Introduction and Business Overview

Table 109. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 110. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings

Table 111. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. Recent Development

Table 112. Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Company Information

Table 113. Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Introduction and Business Overview

Table 114. Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 115. Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings

Table 116. Shanghai SPH New ASIA Pharmaceutical Co., Ltd. Recent Development

Table 117. China Pharmaceutical Holding Group Co., Ltd. Company Information

Table 118. China Pharmaceutical Holding Group Co., Ltd. Introduction and Business Overview

Table 119. China Pharmaceutical Holding Group Co., Ltd. Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 120. China Pharmaceutical Holding Group Co., Ltd. Liposome and Microsphere Delivery System Product Offerings

Table 121. China Pharmaceutical Holding Group Co., Ltd. Recent Development

Table 122. Changzhou Jinyuan Pharmaceutical Co., Ltd. Company Information

Table 123. Changzhou Jinyuan Pharmaceutical Co., Ltd. Introduction and Business Overview

Table 124. Changzhou Jinyuan Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 125. Changzhou Jinyuan Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings

Table 126. Changzhou Jinyuan Pharmaceutical Co., Ltd. Recent Development

Table 127. FormuMax Scientific, Inc. Company Information

Table 128. FormuMax Scientific, Inc. Introduction and Business Overview

Table 129. FormuMax Scientific, Inc. Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 130. FormuMax Scientific, Inc. Liposome and Microsphere Delivery System Product Offerings

Table 131. FormuMax Scientific, Inc. Recent Development

Table 132. Oakwood Labs Company Information

Table 133. Oakwood Labs Introduction and Business Overview

Table 134. Oakwood Labs Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 135. Oakwood Labs Liposome and Microsphere Delivery System Product Offerings

Table 136. Oakwood Labs Recent Development

Table 137. Fuisz Technologies Ltd Company Information

Table 138. Fuisz Technologies Ltd Introduction and Business Overview

Table 139. Fuisz Technologies Ltd Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 140. Fuisz Technologies Ltd Liposome and Microsphere Delivery System Product Offerings

Table 141. Fuisz Technologies Ltd Recent Development

Table 142. Delpharm Company Information

Table 143. Delpharm Introduction and Business Overview

Table 144. Delpharm Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 145. Delpharm Liposome and Microsphere Delivery System Product Offerings

Table 146. Delpharm Recent Development

Table 147. Terumois Company Information

Table 148. Terumois Introduction and Business Overview

Table 149. Terumois Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 150. Terumois Liposome and Microsphere Delivery System Product Offerings

Table 151. Terumois Recent Development

Table 152. Powder Systems Limited Company Information

Table 153. Powder Systems Limited Introduction and Business Overview

Table 154. Powder Systems Limited Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 155. Powder Systems Limited Liposome and Microsphere Delivery System Product Offerings

Table 156. Powder Systems Limited Recent Development

Table 157. PolyMicrospheres Company Information

Table 158. PolyMicrospheres Introduction and Business Overview

Table 159. PolyMicrospheres Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 160. PolyMicrospheres Liposome and Microsphere Delivery System Product Offerings

Table 161. PolyMicrospheres Recent Development

Table 162. AULBIO Company Information

Table 163. AULBIO Introduction and Business Overview

Table 164. AULBIO Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 165. AULBIO Liposome and Microsphere Delivery System Product Offerings

Table 166. AULBIO Recent Development

Table 167. Shanghai Livzon Pharmaceutical Co., Ltd. Company Information

Table 168. Shanghai Livzon Pharmaceutical Co., Ltd. Introduction and Business Overview

Table 169. Shanghai Livzon Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 170. Shanghai Livzon Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings

Table 171. Shanghai Livzon Pharmaceutical Co., Ltd. Recent Development

Table 172. Beijing Biote Pharmaceutical Co., Ltd. Company Information

Table 173. Beijing Biote Pharmaceutical Co., Ltd. Introduction and Business Overview

Table 174. Beijing Biote Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)

Table 175. Beijing Biote Pharmaceutical Co., Ltd. Liposome and Microsphere Delivery System Product Offerings

Table 176. Beijing Biote Pharmaceutical Co., Ltd. Recent Development

Table 177. Key Raw Materials Lists

Table 178. Raw Materials Key Suppliers Lists

Table 179. Liposome and Microsphere Delivery System Downstream Customers

Table 180. Liposome and Microsphere Delivery System Distributors List

Table 181. Research Programs/Design for This Report

Table 182. Key Data Information from Secondary Sources

Table 183. Key Data Information from Primary Sources

List of Figures

Figure 1. Liposome and Microsphere Delivery System Product Picture

Figure 2. Global Liposome and Microsphere Delivery System Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Liposome and Microsphere Delivery System Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Liposome and Microsphere Delivery System Sales Volume (2020-2031) & (K L)

Figure 5. Global Liposome and Microsphere Delivery System Sales Price (2020-2031) & (US$/L)

Figure 6. Liposome and Microsphere Delivery System Report Years Considered

Figure 7. Global Liposome and Microsphere Delivery System Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Liposome and Microsphere Delivery System Players Sales Volume Ranking (2024) & (K L)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Liposome and Microsphere Delivery System Revenue in 2024

Figure 10. Liposome and Microsphere Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Powder Picture

Figure 12. Preparation Picture

Figure 13. Global Liposome and Microsphere Delivery System Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Liposome and Microsphere Delivery System Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Liposome and Microsphere Delivery System Sales Volume by Type (2020 VS 2024 VS 2031) & (K L)

Figure 16. Global Liposome and Microsphere Delivery System Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Liposome and Microsphere Delivery System Price by Type (2020-2031) & (US$/L)

Figure 18. Product Picture of Drug Delivery

Figure 19. Product Picture of Vaccine Development

Figure 20. Product Picture of Diagnostic Imaging

Figure 21. Global Liposome and Microsphere Delivery System Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Liposome and Microsphere Delivery System Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Liposome and Microsphere Delivery System Sales Volume by Application (2020 VS 2024 VS 2031) & (K L)

Figure 24. Global Liposome and Microsphere Delivery System Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Liposome and Microsphere Delivery System Price by Application (2020-2031) & (US$/L)

Figure 26. North America Liposome and Microsphere Delivery System Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Liposome and Microsphere Delivery System Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Liposome and Microsphere Delivery System Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Liposome and Microsphere Delivery System Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Liposome and Microsphere Delivery System Sales Volume (%), (2020-2031)

Figure 38. United States Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Liposome and Microsphere Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Liposome and Microsphere Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 44. China Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 46. China Liposome and Microsphere Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Liposome and Microsphere Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Liposome and Microsphere Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Liposome and Microsphere Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 56. India Liposome and Microsphere Delivery System Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Liposome and Microsphere Delivery System Sales Value by Type (%), 2024 VS 2031

Figure 58. India Liposome and Microsphere Delivery System Sales Value by Application (%), 2024 VS 2031

Figure 59. Liposome and Microsphere Delivery System Industrial Chain

Figure 60. Liposome and Microsphere Delivery System Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!